ORBITAL THERAPEUTICS Trademark
Trademark Overview
On Wednesday, June 12, 2024, a trademark application was filed for ORBITAL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ORBITAL THERAPEUTICS trademark a serial number of 98597164. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 6, 2025. This trademark is owned by Orbital Therapeutics, Inc.. The ORBITAL THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Pharmaceutical preparations in the nature of protein-based therapeutics for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Therapeutic and preventative vaccines; Medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; RNA-based therapeutics for the treatment and prevention of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; Therapeutic agents for the treatment of diseases and disorders related to the immune system, autoimmune disease...
Research and development in the biotechnology field; Consulting services in the fields of biotechnology and genetic science; Development of new technology for others in the fields of genomics and biotechnology; Providing laboratory research services in the field of gene expression or RNA-based therapeutics; Testing, inspection, research, or development of chemical and biotechnology preparations; Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; Design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; Providing information on the subject of scientific and medical research in the fields of biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids
General Information
| Serial Number | 98597164 |
| Word Mark | ORBITAL THERAPEUTICS |
| Filing Date | Wednesday, June 12, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, May 6, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 11, 2025 |
Trademark Statements
| Description of Mark | The mark consists of the word ORBITAL over the word THERAPEUTICS both to the right of a stylized circle with a swirling line around it, the circle and the line both composed of circles of varying sizes. |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Pharmaceutical preparations in the nature of protein-based therapeutics for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Therapeutic and preventative vaccines; Medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; RNA-based therapeutics for the treatment and prevention of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; Therapeutic agents for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Research and development in the biotechnology field; Consulting services in the fields of biotechnology and genetic science; Development of new technology for others in the fields of genomics and biotechnology; Providing laboratory research services in the field of gene expression or RNA-based therapeutics; Testing, inspection, research, or development of chemical and biotechnology preparations; Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; Design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; Providing information on the subject of scientific and medical research in the fields of biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 13, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Orbital Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Orbital Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
Trademark Events
| Event Date | Event Description |
| Wednesday, June 12, 2024 | NEW APPLICATION ENTERED |
| Tuesday, August 13, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 18, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 18, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 18, 2024 | ASSIGNED TO EXAMINER |
| Thursday, February 13, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 13, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 13, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 14, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 5, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 11, 2025 | PUBLISHED FOR OPPOSITION |
| Thursday, August 15, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, December 18, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 11, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 6, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
